Home Tags LegoChem Biosciences

Tag: LegoChem Biosciences

LaNova Medicines and LegoChem to Collaborate in ADC Development

LaNova Medicines, privately held biotech company headquartered in Shanghai, and LegoChem Biosciences, a clinical-stage biopharmaceutical company focusing on the development of next-generation novel therapeutics utilizing its proprietary medicinal drug discovery technology LegoChemistry and the company's patented ADC technology platform* ConjuAll™, have signed a collaborative research agreement to evaluate a novel antibody-drug conjugate (ADC) candidate for an undisclosed target expressed in solid tumors.

SOTIO and LegoChem Biosciences Sign Exclusive Collaboration and License Agreement

Clinical stage immuno-oncology company SOTIO Biotech and LegoChem Biosciences (LCB), a biotechnology company focused on developing its clinical-stage platform technology to develop antibody-drug conjugates...
Featured Image - Laboratory. Courtesy 2019 Fotolia

LegoChem and Iksuda Expand License Agreement

Iksuda Therapeutics and LegoChem Biosciences have confirmed that they have expanded their research collaboration and License Agreement to explore additional ADC programs. The collaboration...

LegoChem Biosciences and Novimmune Start ADC Research Collaboration

Swiss biotech company Novimmune and South Korean LegoChem Bioscience earlier today announced that they have entered into a research collaboration to evaluate a novel...

Takeda and Maverick Therapeutics Develop Novel Biologics Platform to Advance T-Cell...

Maverick Therapeutics, a private start-up biotechnology company that had been solely financed by MPM Capital when it was spun out of its former parent,...
Featured Image: Multiple microscopic slides with stained blood smears, ready for testing. Courtesy: © Fotolia. Used with permission.

Nordic Nanovector and LegoChem Biosciences Collaborate in Developing Novel CD37-Targeting ADC

Earlier today, at the beginning of the pre-connect conference of the 7th World ADC Summit in San Diego, CA, Nordic Nanovector, a biotech company...

LegoChem BioSciences and Fosun Pharma Sign License Agreement for Antibody-drug...

LegoChem Biosciences and Fosun Pharma have have signed a license and commercialization agreement for one of LegoChem’s Next Generation Antibody-Drug Conjugate (ADC) products and...

X